يعرض 5,301 - 5,320 نتائج من 9,062 نتيجة بحث عن 'significant ((((((gap decrease) OR (greatest decrease))) OR (we decrease))) OR (mean decrease))', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 5301

    Supplementary file 1_Global, regional, and national burden of iodine deficiency for women of reproductive age, 1990–2021: a systematic analysis based on the Global Burden of Diseas... حسب Taotao Wang (115296)

    منشور في 2025
    "…Women of 20–24 years showed the highest increase in the age specific incidence rate globally. The significant absolute and relative health inequality was also observed and the gap has been narrowed.…"
  2. 5302

    Supplementary file 1_EEG activity over ipsilateral and contralateral M1 during simple and complex hand tasks: variations with motor learning.docx حسب Jun Zhao (59250)

    منشور في 2025
    "…However, after 10 training sessions, the electrodes over iM1 activation increased during complex tasks but decreased during simple task for both hands, eliminating significant differences in activation levels between simple and complex tasks. …"
  3. 5303

    The effect of cognitive behavioral therapy-based psychoeducation on substance abuse proclivity in adolescent smokers حسب Behiye Dilmen Bayar (19133390)

    منشور في 2025
    "…The difference between the posttest SAPS total mean scores of the control and experimental groups was statistically significant.…"
  4. 5304

    Data for detecting trends in hydroclimatic changes in the Svartberget Krycklan catchment حسب Tejshree Tiwari (12972713)

    منشور في 2024
    "…Looking at runoff, we have observed increasing baseflow during the winter but decreasing baseflow during the summers. …"
  5. 5305

    Image 2_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.tif حسب Fengge Wang (4347442)

    منشور في 2025
    "…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …"
  6. 5306

    Image 1_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.tif حسب Fengge Wang (4347442)

    منشور في 2025
    "…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …"
  7. 5307

    Table 1_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.xlsx حسب Fengge Wang (4347442)

    منشور في 2025
    "…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …"
  8. 5308

    Table 2_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.xlsx حسب Fengge Wang (4347442)

    منشور في 2025
    "…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …"
  9. 5309

    Data_Sheet_1_Investigating the impact of mental rehearsal on prefrontal and motor cortical haemodynamic responses in surgeons using optical neuroimaging.docx حسب Hemel N. Modi (19919895)

    منشور في 2024
    "…Mean objective performance score was significantly higher following MR compared with TR (p = 0.043).…"
  10. 5310

    Data Sheet 1_Real world evidence of dupilumab effectiveness in a Colombian cohort of patients diagnosed with severe asthma.docx حسب Abraham Alí-Munive (21347201)

    منشور في 2025
    "…FEV1 measurements after one or two years of dupilumab treatment were significantly lower than baseline (p = 0.03). Mean change from baseline in FEV<sub>1</sub> was 302.1 ± 481.97 ml (n = 19), 282.00 ± 231.99 ml (n = 10), and 248.18 ± 281.21 ml (n = 11) in the 2–4-, 11–13-, and 19–25-month follow-up periods, respectively. …"
  11. 5311

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity حسب Julian Loureiro (20357035)

    منشور في 2024
    "…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…"
  12. 5312

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity حسب Julian Loureiro (20357035)

    منشور في 2024
    "…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…"
  13. 5313

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity حسب Julian Loureiro (20357035)

    منشور في 2024
    "…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…"
  14. 5314

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity حسب Julian Loureiro (20357035)

    منشور في 2024
    "…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…"
  15. 5315

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity حسب Julian Loureiro (20357035)

    منشور في 2024
    "…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…"
  16. 5316

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity حسب Julian Loureiro (20357035)

    منشور في 2024
    "…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…"
  17. 5317

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity حسب Julian Loureiro (20357035)

    منشور في 2024
    "…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…"
  18. 5318

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity حسب Julian Loureiro (20357035)

    منشور في 2024
    "…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…"
  19. 5319

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity حسب Julian Loureiro (20357035)

    منشور في 2024
    "…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…"
  20. 5320

    First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity حسب Julian Loureiro (20357035)

    منشور في 2024
    "…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…"